Decision Time: Second Circuit Allows Controversial Nonconsensual Third-Party Releases in Purdue Pharma Chapter 11 Plan Join a distinguished panel of lawyers and law professors as they discuss the Second Circuit’s important Purdue Pharma decision. Whether you want to learn more about the circuit’s...
Mediating Bankruptcy Disputes: A Ghost-Runner on Second or Need a New Game? Bankruptcy practice relies on mediation from preferences to chapter 11 plan formulation and confirmation, and many other claims and litigation disputes in a wide variety of settings, including appeals. The use and practice...
Leading Change in the Profession & the Community: Shaping the Future Monique Bair DiSabatino will appear on a panel during the 14th Annual Philadelphia Credit & Restructuring Summit at The Union league of Philadelphia.
In February, 2023, the Antitrust Division of the Department of Justice (“DOJ”) announced they are withdrawing three (3) antitrust policy statements – two of which date from the 1990s – which have been relied upon by healthcare providers and their counsel guiding them through their merger and...
BACKGROUND: The Rule - What It Means and What It Prohibits A somewhat little-known and obscure provision of U.S. antitrust law – Section 8 of the Clayton Act – makes it illegal in certain circumstances for the same person to serve as a director of competing corporations. If certain conditions exist...
LATEST UPDATE The FTC has voted to extend the public comment period on its proposed rule to ban employers from imposing non-competes on their workers, and will now be accepting comments on the proposed rule until April 19, 2023. Comments can still be submitted in either writing or online using the...